KLAS Research honors BD with category leadership for automated dispensing cabinets, traditional smart pumps and EHR-integrated smart pumps

Franklin Lakes, N.J. (Feb. 4, 2026) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its medication management technologies were recognized as 2026 Best in KLAS Award winners across three categories. KLAS Research publishes the Best in KLAS report annually to recognize software and services companies that excel in supporting patient care.

For the seventh consecutive year, BD Pyxis™ MedStation™ ES earned the Best in KLAS Award for Automated Dispensing Cabinets, extending a leadership run unmatched in the category. The BD Alaris™ Infusion System was named Best in KLAS in the categories of Smart Pumps: Traditional (for the second year in a row) and Smart Pumps: Electronic Health Record (EHR) Integrated.

“Connected care is a requirement for modern, resilient health systems,” said Connor Bates, worldwide president of Medication Management Solutions at BD. “Being recognized across multiple categories in the Best in KLAS awards reflects the voice of our customers and reinforces BD’s unrelenting commitment to advancing connected care technology that helps clinicians deliver safer, more efficient care.”

Why Best in KLAS Matters

The Best in KLAS awards are considered an industry benchmark for performance and partnership, reflecting vendor impact in real clinical environments. These wins are based entirely on direct feedback from thousands of healthcare professionals who use medication management solutions every day, underscoring the real-world impact BD technologies have on patient safety and clinical efficiency across the continuum of care.

A Connected, Intelligent Ecosystem for Medication Management

BD’s vision for connected medication management brings together dispensing, infusion and data intelligence to help ensure clinicians have the information and workflows they need at the right moment.

With more than 10 million transactions every day on the BD Alaris™ Infusion System and BD Pyxis™ devices, this technology represents the backbone of hospital operations. This includes advanced capabilities for interoperability with the electronic health record, real-time inventory visibility and data driven decision support, all designed to help hospitals reduce medication errors, improve medication availability and streamline clinical workflows.

The company’s consecutive KLAS recognitions are a powerful testament to BD’s progress in building an increasingly integrated platform that connects technologies across the medication use process. BD’s innovation roadmap continues to focus on delivering intelligent, connected solutions that reinforce safety and strengthen operational performance at scale.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.